+ All Categories
Home > Documents > f01ddiabrtes and Infection

f01ddiabrtes and Infection

Date post: 08-Apr-2018
Category:
Upload: abdel-razek-elmelegi
View: 220 times
Download: 0 times
Share this document with a friend

of 82

Transcript
  • 8/6/2019 f01ddiabrtes and Infection

    1/82

    DIABETES

    AND

    INFECTION

    BY/ Ahmed M.elmeliguiHouse officer (Intern) at kasr elaini hospitals

    Internal medicine Department

  • 8/6/2019 f01ddiabrtes and Infection

    2/82

  • 8/6/2019 f01ddiabrtes and Infection

    3/82

    The objective of this presentationisto try to answer the followingquestions:

    Why diabetics are more prone toinfection ?

    What is the impact of infection ondiabetes ?

    What are the common infections in

    patients with diabetes ?

    INTRODUCTION(CONT.)

  • 8/6/2019 f01ddiabrtes and Infection

    4/82

    INTRODUCTION(CONT.

    ) What are the infections occurring

    predominantly in patients with diabetes

    ?

    What are the principles of preventionand treatment of infections in diabetes

    ? How to manage DM during infection ?

  • 8/6/2019 f01ddiabrtes and Infection

    5/82

    PREDISPOSING FACTORS

    FOR INFECTIONS IN DMPrimary factors

    Granulocyte adherence , chemotaxis.and phagocytic dysfunction.

    Myloperoxidase deficiency.

    Complement pathway. Cytokine-mediated (e.g interleukin-1

    and tumor necrosis factor ).

  • 8/6/2019 f01ddiabrtes and Infection

    6/82

    PREDISPOSING FACTORS

    FOR INFECTIONS IN DMSecondary factors

    Ketoacidosis.

    Frequent hospitalization.

    Gastroparesis ,reflux and aspiration.

    Use of urinary catheters and I.V access

    lines . Delayed wound healing.

    Loss of skin integrity.

    Chronic renal failure and dialysis.

  • 8/6/2019 f01ddiabrtes and Infection

    7/82

    IMPACT OF INFECTION ON

    DMThe stress of infection may worsen

    diabetic control due to

    Release of counter-regulatory hormonessuch as glucagon ,adrenaline andcortisol , which increases hepatic

    glucose release and causeshyperglycemia

    2-Release of cytokines such as IL1 andTNF that affects carbohydrate

    metabolism

  • 8/6/2019 f01ddiabrtes and Infection

    8/82

  • 8/6/2019 f01ddiabrtes and Infection

    9/82

    IMPACT OF INFECTION ON

    DM

    Infection is the mostcommon predisposing causefor diabetic ketoacidosis

    (DKA) and hyperglycemichyperosmolar state (HHS ).

  • 8/6/2019 f01ddiabrtes and Infection

    10/82

    IMPACT OF INFECTION ON

    DM

    Poor food intake and

    vomitingthatassociateseriousinfectionsmaypredispose diabetic

    individualstohypoglycemia.

  • 8/6/2019 f01ddiabrtes and Infection

    11/82

  • 8/6/2019 f01ddiabrtes and Infection

    12/82

    COMMON INFECTIONS IN

    PATIENTS WITH DM

    Urinary tractinfection. Respiratory tractinfections.

    Softtissue infections.

  • 8/6/2019 f01ddiabrtes and Infection

    13/82

    URINARY TRACT

    INFECTIONS

    Asymptomatic bacteruria.

    Acute bacterialcystitis. Fungalcystitis.

    Acute pyelonephritis.

    Perinephricabscess.

  • 8/6/2019 f01ddiabrtes and Infection

    14/82

    URINARY TRACT

    INFECTIONSPredisposing factors

    1-Frequent urinary catheterization.

    2-Autonomic neuropathy.

    vaginitis

    Common pathogens

    E COLI is the commonest.

    Other organisms include Klebsiela,Proteus ,Pseudomonas ,and rarely

    Candida.

  • 8/6/2019 f01ddiabrtes and Infection

    15/82

    URINARY TRACT

    INFECTIONSClinical features

    Lower UTI. Upper UTI.

    Complicated UTI-Perinephric abscess-Papillary necrosis

  • 8/6/2019 f01ddiabrtes and Infection

    16/82

    URINARY TRACT

    INFECTIONSDiagnosis

    Urine microscopic exam., C/S. CBC.

    Blood C/S.

    KUB.Abdominal U/S ,CT.

    Retrograde pyelography.

  • 8/6/2019 f01ddiabrtes and Infection

    17/82

    URINARY TRACT

    INFECTIONSTreatment

    Uncomplicated UTI-Antibiotics.-Trimethoprim-sulphmethoxaxolepotentiates the hypoglycemic effect ofanti-hyperglycemic agents

    Complicated UTI.

    Fungal UTI.

    Bacteriological cure should be confirmed.

  • 8/6/2019 f01ddiabrtes and Infection

    18/82

  • 8/6/2019 f01ddiabrtes and Infection

    19/82

    RESPIRATORY TRACT

    INFECTIONS

    It is unclear whether diabetesconstitutes an independent risk factorfor an increased incidence or severity ofcommon upper or lower respiratorytract infections.

  • 8/6/2019 f01ddiabrtes and Infection

    20/82

    RESPIRATORY TRACTINFECTIONS

    The incidence of bacteraemia ,delayedresolution ,and recurrence is higherfollowing community-acquired

    pneumonia. Infection due to specific

    microorganisms clearly occurs with anincreased frequency in diabetes,including Staph.aureus ,Gram-negative bacteria ,Mycobacterium T.Band Mucor.

  • 8/6/2019 f01ddiabrtes and Infection

    21/82

    RESPIRATORY TRACT

    INFECTIONS

    An other group of infections are

    associated with increased morbidity andmortality ,including infections caused byStreptococci ,Legionella andH.Influenza.

    Individuals with DM have an increasedincidence of T.B and more advanceddisease at the time of diagnosis.

  • 8/6/2019 f01ddiabrtes and Infection

    22/82

  • 8/6/2019 f01ddiabrtes and Infection

    23/82

    SOFT TISSUE INFECTIONS Pyomyositis

    -Refer to infection of muscleswithout infection ofcontiguous tissue by Staph.aureus throughhaematogenous spread ,withabscess formation followingminor trauma andhaematoma formation.-Clinical featuresincludespain ,fever and swelling withpocket of pus formation.-CTor MRI may be neededto define the location andextent of the abscess.

  • 8/6/2019 f01ddiabrtes and Infection

    24/82

  • 8/6/2019 f01ddiabrtes and Infection

    25/82

    INFECTIONS OCCURRING

    PREDOMINANTLY WITH DM

    Malignant /Invasive otitis externa.

    Rhinocerebralmucormycosis.

    Necrotizingfascitis.

    Fournier'sgangrene.

    Emphysematouscholecystitis. Emphysematouspyelonephritisandcystitis.

    Renalpapillary necrosis

  • 8/6/2019 f01ddiabrtes and Infection

    26/82

    MALIGNANT/INVASIVE

    OTITIS EXTERNA Occurs in elderly diabetics and

    involves external auditory canal and

    skull.

    Potentially life-threatening infection.

    The majority of cases are caused by

    Pseud.aeruginosa ,rarely secondaryto colonization of external ear canalby Aspergillus species.

  • 8/6/2019 f01ddiabrtes and Infection

    27/82

    MALIGNANT / INVASIVE

    OTITIS EXTERNAClinical features

    Ear discharge ,severe painandhearing

    impairment . Oedema ,intense cellulitisandpolypoid

    tissue are seeninexternalearcanal.

    Cranialosteomylitisandintracranialspreadofinfectionmayoccur.

    Facial nerve involvementmayoccur .

  • 8/6/2019 f01ddiabrtes and Infection

    28/82

    MALIGNANT / INVASIVE

    OTITIS EXTERNADiagnosis

    Gram'sstain ,culture andbiopsyofdebridednecrotictissue.

    MRI maybe needed todefine softtissue andbone involvement.

    D.D:uncomplicatednon-invasive otitisexternaandepidermalcarcinoma.

  • 8/6/2019 f01ddiabrtes and Infection

    29/82

    MALIGNANT / INVASIVE

    OTITIS EXTERNA

  • 8/6/2019 f01ddiabrtes and Infection

    30/82

    MALIGNANT / INVASIVE

    OTITIS EXTERNA

  • 8/6/2019 f01ddiabrtes and Infection

    31/82

    MALIGNANT / INVASIVE OTITISEXTERNA

    Treatment

    Early referral to otolaryngologist iscrucial.

    Repeated surgical debridment ofnecrotic tissue.

    Systemic antipseudomonalantibiotics.

    Adjunctive topical antibiotic or aceticacid drops.

    Duration of therapy is often 4-6

    weeks or longer

  • 8/6/2019 f01ddiabrtes and Infection

    32/82

  • 8/6/2019 f01ddiabrtes and Infection

    33/82

    RHINOCEREBRAL

    MUCORMYCOSIS Five clinical forms of mucormycosis :Rhinocerebral ,pulmonary

    ,gastrointestinal , primary cutaneousand disseminated.

    Rhinocerebral type has the highest

    frequency and mortality.

  • 8/6/2019 f01ddiabrtes and Infection

    34/82

    RHINOCEREBRAL

    MUCORMYCOSIS

    RhizopusspMucorspecies

  • 8/6/2019 f01ddiabrtes and Infection

    35/82

    RHINOCEREBRAL

    MUCORMYCOSIS 50% of cases occur in patients with DM.

    Usually occurs during an episode ofDKA , with disruption of host defensemechanisms ,thereby permitting growthofRhizopus oryzae. Such growth is

    inhibited by correction of acidosis.

  • 8/6/2019 f01ddiabrtes and Infection

    36/82

    RHINOCEREBRAL

    MUCORMYCOSISClinical features

    Onset with nasal stuffiness ,epistaxis

    and facial pain. Later ,proptosis , chemosis and

    ophthalmoplegia.

    Fever and confusion. Black necrotic eschar on the nasal

    turbinates or palate :verycharacteristic

  • 8/6/2019 f01ddiabrtes and Infection

    37/82

    RHINOCEREBRAL

    MUCORMYCOSISComplications

    Cavernous sinus thrombosis.

    Multiple cranial nerve palsies.

    Visual loss.

    Frontal lobe abscess. Carotid artery or jugular vein

    thrombosis causing hemiparesis.

  • 8/6/2019 f01ddiabrtes and Infection

    38/82

    RHINOCEREBRAL

    MUCORMYCOSIS

  • 8/6/2019 f01ddiabrtes and Infection

    39/82

    RHINOCEREBRAL

    MUCORMYCOSIS

  • 8/6/2019 f01ddiabrtes and Infection

    40/82

    RHINOCEREBRAL

    MUCORMYCOSIS

  • 8/6/2019 f01ddiabrtes and Infection

    41/82

    RHINOCEREBRAL

    MUCORMYCOSIS

  • 8/6/2019 f01ddiabrtes and Infection

    42/82

    RHINOCEREBRAL

    MUCORMYCOSISDiagnosis

    Punch biopsy of the lesion followed by

    fungal stains and culture. Histological examination reveals the

    characteristic broad , branching hyphae

    ofRhizopus invading the tissue.

    CT or MRI of the head reveal air-fluidlevel in the sinuses and involvement ofdeep tissues

  • 8/6/2019 f01ddiabrtes and Infection

    43/82

    RHINOCEREBRAL

    MUCORMYCOSISTreatment

    Aggressive surgical debridement anddrainage of the infected sinuses.

    Systemic amphotericin B.

    More recently , liposomal amphotercin-B has been used.

  • 8/6/2019 f01ddiabrtes and Infection

    44/82

    NECROTIZING FASCIITIS Uncommon soft tissue infection that

    spreads along fascial planes with

    relatively initial sparing of skin andunderlying muscles.

    However , as the infection progresses

    skin may be necrosed due tothrombosis of cutaneouse vessels

  • 8/6/2019 f01ddiabrtes and Infection

    45/82

    NECROTIZING FASCIITIS

    Two bacteriological types Type 1

    -Caused by a combination of at least oneanaerobe and one or more facultative

    anaerobe such as streptococci or enterococci. Type 2

    -Caused by group A , B-hemolytic streptococciwith or without staphylococci.

    Release of endogenous cytokines and bacterialtoxins cause tissue damage and systemictoxicity

  • 8/6/2019 f01ddiabrtes and Infection

    46/82

    NECROTIZING FASCIITISClinical features

    Abdominal wall , perineum and

    extremities are the most common sites. The source of introduction of the

    pathogen may be unknown or may

    follow surgery , minor trauma ,spreadfrom distant sites or a Barrtholins glandabscess .

  • 8/6/2019 f01ddiabrtes and Infection

    47/82

    NECROTIZING FASCIITIS

    Clinical features Early :Severe local pain with few local

    signs.

    Fever and marked toxicity. Rapid spread of infection along unseen

    fascial planes to involve contiguous areas

    away from the original site ofinvolvement.

    Thrombosis leads to serous andhemorrhagic bullae ,gangrene and

    ulceration.

  • 8/6/2019 f01ddiabrtes and Infection

    48/82

    NECROTIZING FASCIITISClinical features

    Crepitus is palpable inapproximately 50% of

    cases. Dishwater pus due to

    liquefactive necrosis.

    Lymphadenitis andlymphangitis are rare.

    Destruction ofsubcutaneous nervesleads to anaethesia.

  • 8/6/2019 f01ddiabrtes and Infection

    49/82

    NECROTIZING FASCIITISDiagnosis

    A high index of suspicion.

    The ability to pass a probe easily alongnormally adherent fascial planes.

    Gram's stain and culture of samplefrom necrotic centre.

    Plain X- ray , U/S , CT and MRI.

  • 8/6/2019 f01ddiabrtes and Infection

    50/82

    NECROTIZING FASCIITISTreatment

    Early and adequate surgical debridement

    and fasciotomy play a key role inreducing mortality.

    Systemic combination antibiotics :-Start with penicillin or cephalosporin +

    aminoglycoside with clidamycin ormetronidazole.-Then according to results of C/S.

  • 8/6/2019 f01ddiabrtes and Infection

    51/82

    NECROTIZING FASCIITIS

  • 8/6/2019 f01ddiabrtes and Infection

    52/82

    NECROTIZING FASCIITIS

  • 8/6/2019 f01ddiabrtes and Infection

    53/82

    NECROTIZING FASCIITISM

    RI

  • 8/6/2019 f01ddiabrtes and Infection

    54/82

    FOURNIERS GANGRENE First described by the French venereologist

    Fournier in 1882.

    A syndrome of synergistic , polymicrobial,necrotizing fascitis of the perineum,scrotum and penis.

    30 60%0f cases have underlying DM.

    Other predisposing factors includealcoholism , steroid abuse ,cancerchemotherapy and AIDS.

  • 8/6/2019 f01ddiabrtes and Infection

    55/82

    FOURNIERS GANGRENE

    Diagnosis

    Predominantly clinical.Treatment

    Surgical emergency with extensive

    surgery. Proper systemic antibiotics and

    supportive care.

    Prognosis

    High mortality rate specially withadvanced age ,extensive disease ,deranged renal function ,sepsis and

    shock

  • 8/6/2019 f01ddiabrtes and Infection

    56/82

    FOURNIER,S GANGRENE

  • 8/6/2019 f01ddiabrtes and Infection

    57/82

    FOURNIER,S GANGRENE

  • 8/6/2019 f01ddiabrtes and Infection

    58/82

    EMPHYSEMATOUS

    CHOLECY

    STITIS Rare variant of acute cholecystitis

    caused by ischemia of the gall bladder

    wall and infection with gas -producingorganisms.

    35- 55% of cases have DM.

    Thought to result from acalculous cysticduct obstruction , with inflammatoryoedema causing cystic artery occlusionfollowed by infection with gas-forming

    organisms

    EMPHYSEMATOUS

  • 8/6/2019 f01ddiabrtes and Infection

    59/82

    EMPHYSEMATOUSCHOLECYSTITIS

    Clinical features Clinically similar to acute cholecystitis

    However

    Male predominance. Gangrene and perforation ofGB is

    more common

    Toxicity is marked Gall stones are present in only 50% .

    Mortality is higher ( 15% vs. less than

    4 % )

  • 8/6/2019 f01ddiabrtes and Infection

    60/82

  • 8/6/2019 f01ddiabrtes and Infection

    61/82

    EMPHYSEMATOUS

    CHOLECY

    STITIS

    Treatment

    Early cholecystectomy is crucial.

    Proper antibiotics and supportive care

  • 8/6/2019 f01ddiabrtes and Infection

    62/82

    EMPHYSEMATOUS

    CHOLECY

    STITIS

    EMPHYSEMATOUS

  • 8/6/2019 f01ddiabrtes and Infection

    63/82

    EMPHYSEMATOUSPYELONEPHRITIS

    Rare necrotizing infection of the renalparenchyma and perirenal tissue thatis characterized by gas formation.

    Over 90% of cases occur in diabeticcases.

    The most common causativepathogens are E.coli ,Proteus mirabilis

    and Klebsiella pneumoniae thatferment glucose, lactate ,andproducts from necrotic tissue tocarbon dioxide ,hydrogen ,nitrogen

    and unknown gases .

  • 8/6/2019 f01ddiabrtes and Infection

    64/82

    EMPHYSEMATOUS

    PY

    ELONEPHRITISClinical features

    Chills ,fever ,flank pain ,dysuria ,nausea

    and vomiting , lethargy and alteredsensorium, shock.

    Crepitusif spread of infection to theperirenal space.

    Bilateral involvement may occurinfrequently.

  • 8/6/2019 f01ddiabrtes and Infection

    65/82

    EMPHYSEMATOUS

    PY

    ELONEPHRITISDiagnosis Failure of fever to resolve within 3-4 days

    should raise the possibility of this infection. Leucocytosis and pyuria and +ve blood

    culture Thrombocytopenia. Abdominal plain X ray and U/S diagnostic in

    85%. Abdominal CT scan is diagnostic. Increased create level.

  • 8/6/2019 f01ddiabrtes and Infection

    66/82

  • 8/6/2019 f01ddiabrtes and Infection

    67/82

    EMPHYSEMATOUS

    PY

    ELONEPHRITISTreatment

    Proper I.V antibiotics and vigoroushydration.

    Surgery : nephrectomy vs.conservative approach with drainage of

    the affected kidney with aggressivemedical treatment.

  • 8/6/2019 f01ddiabrtes and Infection

    68/82

    EMPHYSEMATOUS

    PY

    ELONEPHRITIS

    Complications

    Acute renal failure. Renal papillary necrosis.

    Septicemia.

  • 8/6/2019 f01ddiabrtes and Infection

    69/82

    EMPHYSEMATOUS

    PY

    ELITIS This entity is distinct from

    emphysematous pyelonephritis , as gas

    is localized to the renal collectingsystem.

    Radiography reveals gas following theoutlines of the renal pelvis.

    I.V antibiotics and relieving theobstruction are sufficient therapy.

    Mortality is lower.

  • 8/6/2019 f01ddiabrtes and Infection

    70/82

    EMPHYSEMATOUS

    CY

    STITIS Associated with vesiccolic or vesicovaginal

    fistula.

    Characteristic features include pneumaturiaor may be haematuria.

    Radiology shows air in the bladder wall,intramural air bubbles , or an air-fluid level in

    the lumen. Antibiotics and relief of bladder outlet

    obstruction are therapeutic.

  • 8/6/2019 f01ddiabrtes and Infection

    71/82

    RENAL PAPILLARY

    NECROSIS Necrosis and sloughing of the renal

    papillae are five times more

    prevalent in diabetic than in non-diabetic patients.

    Clinical features

    Persistent fever and flank paindespite being on antibiotics.

    ,

  • 8/6/2019 f01ddiabrtes and Infection

    72/82

    RENAL PAPILLARY

    NECROSISDiagnosis

    Voided medullary tissue on urinalysis.

    Retrograde pyelogram is diagnostic .a(ringsign) is present when a separatedpapilla is surrounded by contrastmedium. This may show calcification.

    Treatment

    Parenteral antibiotics.

    Drainage to relieve obstruction.

  • 8/6/2019 f01ddiabrtes and Infection

    73/82

    RENAL PAPILLARY

    NECROSIS U/S

  • 8/6/2019 f01ddiabrtes and Infection

    74/82

  • 8/6/2019 f01ddiabrtes and Infection

    75/82

    PREVENTION OF

    INFECTION IN DIABETICS Patients with well controlled diabetes

    are no more susceptible to infection

    than patients without diabetes. Good general and foot hygiene is

    crucial.

    Influenza and pneumoccal vaccination.

  • 8/6/2019 f01ddiabrtes and Infection

    76/82

    USE OF ANTIBIOTICS IN

    DM: SPECIALCONSIDERATIONS Particular caution is warranted to

    avoid nephrotoxicity and eye toxicity. When administering oral antibiotics ,

    the effects of gastropathy on oral

    absorption should be considered. Effect of some antibiotics on glycemic

    state should be cosidered.

  • 8/6/2019 f01ddiabrtes and Infection

    77/82

    MANAGEMENT OF DM

    DURING INFECTION

    The challenge is to achievestrict near-normal glycemicstate , provide adequate

    nutrition andminimize the risk ofhypoglycemia.

    G O

  • 8/6/2019 f01ddiabrtes and Infection

    78/82

    MANAGEMENT OF DM

    DURING INFECTIONNear-normal glycemic state

    For optimal wound healing and

    phagocytic function BG should notexceed 150 mg/ dl.

    Recent recommendation advise to keep

    BG around 110 mg/dl to improvehealth outcome during critical illnessincluding serious infections

    MANAGEMENT OF DM

  • 8/6/2019 f01ddiabrtes and Infection

    79/82

    MANAGEMENT OF DM

    DURING INFECTIONNear-normal glycemic state

    To achieve these BG targets insulin is

    usually needed. Common insulin regimen used during

    acute illness include :-Basal- bolus regime.

    -DEXTROSE-POTASIUM-INSULIN (DKI) -Separate I.V. infusion of dextrose andinsulin

  • 8/6/2019 f01ddiabrtes and Infection

    80/82

    TAKE-HOME MESSAGE

    Search for an occult infection ifDM is difficult to control.

    Treat infection aggressively indiabetic individuals.

    Monitor BG closelyduringinfection to ensure strictglycemic control and avoid

    hypoglycemia. Early identify ,refer and treat

    life- threatening infections indiabetic individuals

  • 8/6/2019 f01ddiabrtes and Infection

    81/82

  • 8/6/2019 f01ddiabrtes and Infection

    82/82


Recommended